|
| R-121,919 Basic information |
Product Name: | R-121,919 | Synonyms: | R-121,919;3-(6-(DIMETHYLAMINO)-4-METHYLPYRIDIN-3-YL)-2,5-DIMETHYL-N,N-DIPROPYLPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE;NBI 30775;3-[6-(diMethylaMino)-4-Methyl-3-pyridinyl]-2,5-diMethyl-N,N-dipropyl-pyrazolo[2,3-a]pyriMidine-7-aMine;3-(6-(Dimethylamino)-4-methylpyridin-3-yl)-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-am;3-[6-(DiMethylaMino)-4-Methyl-3-pyridinyl]-2,5-diMethyl-N,N-dipropylpyrazolo[1,5-a]pyriMidin-7-aMine;-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine;-4-methylpyridin-3-yl) | CAS: | 195055-03-9 | MF: | C22H32N6 | MW: | 380.53 | EINECS: | | Product Categories: | | Mol File: | 195055-03-9.mol | |
| R-121,919 Chemical Properties |
density | 1.11±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 6.2 mg/mL (16.29 mM) | pka | 6.33±0.10(Predicted) |
| R-121,919 Usage And Synthesis |
Uses | 3-[6-(Dimethylamino)-4-methyl-3-pyridinyl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine, is a potent and Orally active Corticotropin-Releasing factor 1 receptor antagonists, which is hown to reduce negative emotional symptoms of acute and protracted alcohol withdrawal, and thus used for the treatment of alcoholism. |
| R-121,919 Preparation Products And Raw materials |
|